CONTEXT THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
CONTEXT THERAPEUTICS INC. (CNTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $1.58 per share as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $1.58.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $1.60.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $1.33.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $1.33.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $1.58 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.60 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.33 10-K · filed 2026-03-23 |
| 2025-09-30 | $1.33 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.34 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.51 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.97 10-K · filed 2025-03-20 |
| 2024-09-30 | $1.97 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.94 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.93 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.20 10-K · filed 2024-03-21 |
| 2023-09-30 | $2.28 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.26 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.35 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.27 10-K · filed 2023-03-22 |
| 2022-09-30 | $3.27 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.27 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.48 10-Q · filed 2022-05-11 |
| 2021-12-31 | $5.68 10-K · filed 2022-03-23 |
| 2021-09-30 | $5.69 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |